Table 2 Differences in DUSP1 methylation frequency between tumour DNA and PBLa DNA in breast cancer patients.

From: DUSP1 promoter methylation in peripheral blood leukocyte is associated with triple-negative breast cancer risk

PBL DNAa

Tumour tissue DNA

Total No. (%)

P-valueb

Methylated No. (%)

Unmethylated No. (%)

Methylated No. (%)

3 (1.94)

2 (1.29)

5 (3.23)

0.000

Unmethylated No. (%)

80 (51.61)

70 (45.16)

150 (96.77)

 

Total No. (%)

83 (53.55)

72 (46.45)

155 (100)

 
  1. aPBL, peripheral blood leukocytes. bP-value was generated by McNemar Test.